The One, Big, Beautiful Bill | Drug Prices Debated | Markets Soar After US-China Tariff Deal
Failed to add items
Add to basket failed.
Add to Wish List failed.
Remove from Wish List failed.
Follow podcast failed
Unfollow podcast failed
The One, Big, Beautiful Bill | Drug Prices Debated | Markets Soar After US-China Tariff Deal
-
Narrated by:
-
By:
About this listen
In this week’s episode of The Elliot Omanson Show, we break down the GOP’s newly proposed “One Big, Beautiful Bill” — and challenge the media’s narrative around it. Our focus is on the controversial Medicaid changes and spending cuts, with a take you won’t hear on most mainstream media.
We also unpack President Trump’s latest executive order aimed at lowering prescription drug prices through a “most-favored-nation” pricing model — a move that aligns U.S. costs with what other developed countries pay. Ironically, it's a policy many Democrats once supported… until Trump signed it.
Lastly, we cover the breakthrough U.S.–China trade talks in Geneva, where both countries agreed to drop tariffs by a staggering 115%. U.S. tariffs on Chinese goods drop to 30%, while China slashes its tariffs to just 10%. Markets surged on the news, with the Nasdaq and S&P 500 posting strong gains.
With trade momentum building, jobs strong, and inflation cooling — we think the American economy is poised to thrive.